wellrank.ai
Willow logo

Willow

First cited by AI Jun 26, 2026
onewillow.com

Surfaced organically in AI answers about compounded glp-1s. Not yet profiled.

Willow is losing the AEO war.

Not cited in a single tracked AI answer since Jun 30, 2026, down from a peak of 2% visibility in compounded glp-1s on Jun 26, 2026. This page stays public, and recovery shows here the day it happens.

AI Visibility

Visibility trend

Compounded GLP-1s, daily share of AI answers mentioning Willow, through Jul 5, 2026.

0.0%

Last cited Jun 30, 2026 · peak 2% on Jun 26

By engine

Where Willow is strong, and where it is invisible.

  • No engine data yet.

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 0 positive mentions
  • 0 neutral
  • 1 mixed or cautious

Recent AI answers mentioning Willow

PerplexityJun 26, 2026, 13:30 UTC
Is compounded tirzepatide still available anywhere legitimate?

No, compounded tirzepatide is no longer available through legitimate regular pharmacies as of March 19, 2025, because the FDA officially ended the tirzepatide shortage and banned widespread compounding of the medication[1][2]. The only legitimate way to access tirzepatide is through the FDA-approved brand-name products Mounjaro (for type 2 diabetes) and Zepbound (for weight loss), which you must obtain via a prescription from a licensed healthcare provider[1][2]. While some online telehealth platforms (such as Ivím Health, Willow, and Trim RX) still advertise compounded tirzepatide by claiming it is legal under federal compounding statutes if prescribed for an individual patient with a medical need[6][9], these preparations are not FDA-approved as finished drugs and exist in a legal gray area following the FDA’s final ruling and the expiration of grace periods for compounding pharmacies[1][2]. The FDA explicitly warns that any tirzepatide sold without a prescription is not legitimate and may be unauthorized or counterfeit, posing serious health risks[2]. If you are looking for a safe and approved treatment, consult your doctor about Mounjaro or Zepbound. If these are difficult to access due to cost or availability, your provider may also discuss alternative GLP-1 medications like compounded semaglutide (which may still be allowed if semaglutide remains on the FDA shortage list) or other FDA-approved options[1][3].

Mentioned in position 4 of 5

Read full answer with sources →

Competitive Landscape

Willow vs the brands AI recommends alongside it

The real competitive set in Compounded GLP-1s: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Willow logo
WillowThis brand
0.0%
Ivím Health logo
Ivím Health

1 shared answers

#57
1.7%
Mounjaro logo
Mounjaro

1 shared answers

#12
8.3%
Zepbound logo
Zepbound

1 shared answers

#13
8.3%

Email me when overtakes Willow

One email the day the ranks flip. Nothing else.

Sources cited around Willow

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Willow weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Willow? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.